Howard Hughes Medical Institute’s VeriSign VRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-18
Closed -$4.37K 464
2025
Q4
$4.37K Hold
18
﹤0.01% 369
2025
Q3
$5.03K Buy
18
+1
+6% +$279 ﹤0.01% 338
2025
Q2
$4.91K Buy
+17
New +$4.61K ﹤0.01% 337
2014
Q2
Sell
-2,501
Closed -$135K 237
2014
Q1
$135K Buy
2,501
+707
+39% +$40K 0.02% 103
2013
Q4
$107K Sell
1,794
-907
-34% -$49.9K 0.02% 127
2013
Q3
$137K Sell
2,701
-1,402
-34% -$67.7K 0.02% 107
2013
Q2
$183K Buy
+4,103
New +$190K 0.06% 97

Other funds holding VRSN

Howard Hughes Medical Institute's VRSN Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of VeriSign (VRSN) in Q1 2026, closing a stake of 18 shares — an estimated $4.37K sold.

Howard Hughes Medical Institute first reported a position in VRSN in Q2 2013 and held it in 7 quarters. The position peaked at $183K in Q2 2013. 847 funds tracked by Wall St. Rank hold VRSN as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining VeriSign position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 18 VeriSign shares in Q1 2026, an estimated $4.37K.
  • Howard Hughes Medical Institute first reported a position in VeriSign in Q2 2013 and held it in 7 quarters.
  • Howard Hughes Medical Institute's VeriSign position peaked at $183K in Q2 2013.
  • 847 funds tracked by Wall St. Rank held VeriSign as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.